Comparative analysis of three NGS platforms assessing tumor mutational burden and mutational landscape in resectable non-small cell lung cancer

被引：0
|
作者：
Lee, J. B. [1 ]
Choi, S. J. [2 ]
Kim, J. H. [2 ]
Hong, M. H. [1 ]
Cho, B. C. [1 ]
Lim, S. M. [1 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Yonsei Canc Ctr, Div Oncol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
481P
引用
收藏
页码：S1649 / S1649
页数：1
相关论文
共 50 条
  • [31] Tumor Mutational Burden in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy: Outcomes in a Multiethnic Cohort
    Munoz-Arcos, L.
    D'Aiello, A.
    Herbert, J.
    Cheng, H.
    Halmos, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S408 - S409
  • [32] The heterogeneous metabolic and mutational landscape of non-small cell lung carcinomas
    Van Zon-Meijer, T.
    Peeters, W.
    Looijen-Salamon, M.
    Biemans, R.
    Dubois, L.
    Span, P.
    Bussink, J.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S598 - S599
  • [33] Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ma, Yuhui
    Li, Quan
    Du, Yaxi
    Cai, Jingjing
    Chen, Wanlin
    Zhao, Guangqiang
    Liu, Xing
    Li, Hongsheng
    Ma, Luyao
    Huang, Yunchao
    Zhou, Yongchun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] Association of tumor mutational burden with clinical, genomic, and treatment characteristics in advanced non-small cell lung cancer
    Willis, Connor
    Bauer, Hillevi
    Au, Trang
    Unni, Sudhir
    Akerley, Wallace
    Sekhon, Ashley
    Badin, Firas
    Villano, John
    Schabath, Matthew
    Xia, Bing
    Gustafson, Beth
    Gupte-Singh, Komal
    Korytowsky, Beata
    Thomas, John-Michael
    Krigsfield, Gabriel
    Lubinga, Solomon
    Brixner, Diana
    Stenehjem, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [35] Tumor mutational burden assessed by a targeted NGS assay predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer
    Jermann, P.
    Alborelli, I.
    Leonards, K.
    Rothschild, S. I.
    Leuenberger, L.
    Prince, S. Savic
    Mertz, K.
    Poechtrager, S.
    Zippelius, A.
    Quagliata, L.
    Bubendorf, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] Predictive value of tumor mutational burden for immunotherapy in non-small cell lung cancer: A systematic review and meta-analysis
    Meng, Guangxian
    Liu, Xiaowei
    Ma, Tian
    Lv, Desheng
    Sun, Ge
    PLOS ONE, 2022, 17 (02):
  • [37] Harmonization study of tumour mutational burden determination in non-small cell lung cancer (NSCLC)
    Garrido-Martin, E. M.
    Ramos-Paradas, J.
    Prieto, S. Hernandez
    Sanchez, E.
    Rosado, A.
    Caniego-Casas, T.
    Carrizo, N.
    Enguita, A. B.
    Munoz-Jimenez, M. T.
    Rodriguez, B.
    Perez-Gonzalez, U.
    Gomez Sanchez, D.
    Ferrer, I.
    Ponce Aix, S.
    Nunez Buiza, A.
    Garrido, P.
    Palacios, J.
    Lopez-Rios, F.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 852 - 852
  • [38] Tumor mutational burden assessed by a targeted NGS assay to predict clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
    Rothschild, Sacha
    Alborelli, Ilaria
    Leonards, Katharina
    Leuenberger, Laura P.
    Prince, Spasenija Savic
    Mertz, Kirsten D.
    Poechtrager, Severin
    Zippelius, Alfred
    Laubli, Heinz Philipp
    Haegele, Jasmin
    Tolnay, Markus
    Bubendorf, Lukas
    Quagliata, Luca
    Jermann, Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors
    Berland, Lea
    Heeke, Simon
    Humbert, Olivier
    Macocco, Adam
    Long-Mira, Elodie
    Lassalle, Sandra
    Lespinet-Fabre, Virginie
    Lalvee, Salome
    Bordone, Olivier
    Cohen, Charlotte
    Leroy, Sylvie
    Hofman, Veronique
    Hofman, Paul
    Ilie, Marius
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S71 - S80
  • [40] Cancer Testis Antigens and Mutational Load in Relation to the Immune Landscape of Non-Small Cell Lung Cancer
    Backman, M.
    Kurppa, P.
    Djureinovic, D.
    La Fleur, L.
    Persson, J.
    Mattsson, J.
    Botling, J.
    Branden, E.
    Koyi, H.
    Ponten, F.
    Micke, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1820 - S1820
12345